Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DELORAZEPAM Cause Toxicity to various agents? 171 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Toxicity to various agents have been filed in association with DELORAZEPAM. This represents 9.8% of all adverse event reports for DELORAZEPAM.

171
Reports of Toxicity to various agents with DELORAZEPAM
9.8%
of all DELORAZEPAM reports
78
Deaths
72
Hospitalizations

How Dangerous Is Toxicity to various agents From DELORAZEPAM?

Of the 171 reports, 78 (45.6%) resulted in death, 72 (42.1%) required hospitalization, and 21 (12.3%) were considered life-threatening.

Is Toxicity to various agents Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DELORAZEPAM. However, 171 reports have been filed with the FAERS database.

What Other Side Effects Does DELORAZEPAM Cause?

Drug abuse (834) Sopor (630) Intentional self-injury (422) Intentional overdose (200) Suicide attempt (174) Overdose (114) Intentional product misuse (99) Coma (98) Somnolence (96) Confusional state (94)

What Other Drugs Cause Toxicity to various agents?

OXYCODONE (17,518) ACETAMINOPHEN (16,128) FENTANYL (15,546) MORPHINE (15,337) BUPRENORPHINE (10,906) HYDROMORPHONE (10,769) HYDROCODONE (10,645) ACETAMINOPHEN\OXYCODONE (10,568) ACETAMINOPHEN\HYDROCODONE (10,343) TAPENTADOL (9,617)

Which DELORAZEPAM Alternatives Have Lower Toxicity to various agents Risk?

DELORAZEPAM vs DELTA.8-TETRAHYDROCANNABINOL\HERBALS DELORAZEPAM vs DEMCIZUMAB DELORAZEPAM vs DEMEROL DELORAZEPAM vs DENOSUMAB DELORAZEPAM vs DEOXYCHOLIC ACID

Related Pages

DELORAZEPAM Full Profile All Toxicity to various agents Reports All Drugs Causing Toxicity to various agents DELORAZEPAM Demographics